SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is attracting significant community attention and discussion, particularly as its proponents rally around the upcoming 4/20 event, promoting its mission to advance global cannabis culture and legalization on the Solana blockchain as a crypto 'like Bitcoin but way higher'.

ProShares Trust - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

ProShares Ultra VIX Short-Term Futures ETF (UVXY) is trending due to ongoing geopolitical tensions and market uncertainty, with investors actively debating its potential for significant volatility spikes as a hedge against downturns, while others focus on shorting rallies given its inherent decay.

Velo3D, Inc. operates as a technology company, which engages in developing and manufacturing metal laser sintering printing machines for 3D printing. Its products include assure system, flow software, sapphire printer & sapphire XC. The company was founded by Benyamin Buller in June 2014 and is headquartered in Fremont, CA.

Velo3D Inc

Velo3D is trending due to new partnerships, including a U.S. Army collaboration for ground vehicle parts and a successful fuel tank development with Momentus. The community is actively discussing the company's critical role in advancing defense and space manufacturing with its unique metal 3D printing technology, anticipating further significant contracts.

Ginkgo Bioworks Holdings, Inc. is a biotech company. Its platform enables biotechnology applications across diverse markets, from food, agriculture, industrial chemicals, and pharmaceuticals. It operates through the Cell Engineering and Biosecurity segments. The Cell Engineering segment consists of end-to-end cell engineering solutions and cell engineering tools offerings for biological research and development. The Biosecurity segment focuses on biomonitoring and bioinformatics support services, offered to both government and non-government customers through the company's two core offerings, Canopy and Horizon. The company was founded by Jason Kelly, Reshma Shetty, Bartholomew Canton, Austin Che, and Thomas F. Knight, Jr. in 2008 and is headquartered in Boston, MA.

Ginkgo Bioworks Holdings Inc - Ordinary Shares - Class A

Ginkgo Bioworks is trending as its collaboration with OpenAI on an AI-driven autonomous lab, achieving significant cost reductions in protein synthesis, sparks community debate on its potential as critical national biotechnology infrastructure amid broader sector tailwinds for AI and biodefense.

Direxion Shares ETF Trust - Direxion Daily S&P Biotech Bear 3X Shares

Direxion Daily S&P Biotech Bear 3X Shares

LABD is trending amidst community frustration and significant losses as the biotech sector (XBI) maintains an unexpected bull run, driven by ongoing M&A and perceived market manipulation, defying numerous bearish technical indicators.

Roku, Inc. engages in the provision of a streaming platform for television. It operates through the Platform and Devices segments. The Platform segment includes digital advertising and related services including the demand-side platform and content distribution services such as subscription and transaction revenue shares, media and entertainment promotional spending, the sale of premium subscriptions, and the sale of branded channel buttons on remote controls. The Devices segment is involved in the sale of streaming players, audio products, smart home products, and accessories that are sold through retailers and distributors, as well as directly to customers through the company’s website. The company was founded by Anthony J. Wood in October 2002 and is headquartered in San Jose, CA.

Roku Inc - Ordinary Shares - Class A

Roku Inc

Roku is trending due to a flurry of analyst upgrades from multiple firms, including a significant double-upgrade from Morgan Stanley, highlighting increasing confidence in its growing ad platform and upcoming catalysts like the Amazon DSP partnership, Winter Olympics, and midterm political ad spending. The community is actively debating whether the stock's recent volatility, despite these bullish sentiments and raised price targets, presents a buying opportunity ahead of its anticipated earnings report.

The Goldman Sachs Group, Inc. engages in the provision of financial services. It operates through the following business segments: Global Banking and Markets, Asset and Wealth Management, and Platform Solutions. The Global Banking and Markets segment includes investment banking, global investments, and equity and debt investments. The Asset and Wealth Management segment relates to the direct-to-consumer banking business which includes lending, deposit-taking, and investing. The Platform Solutions segment includes consumer platforms such as partnerships offering credit cards and point-of-sale financing, and transaction banking. The company was founded by Marcus Goldman in 1869 and is headquartered in New York, NY.

Goldman Sachs Group, Inc.

Goldman Sachs is generating significant buzz following robust Q4 earnings and a dividend increase, alongside strategic AI adoption to streamline operations and capitalize on a strong rebound in investment banking. While many in the community are bullish on its upward trajectory and M&A leadership, there's also heated discussion around the firm's influence on market movements and its recent downgrade of a popular tech stock.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers is trending amidst sharp debate after its launch of a compounded GLP-1 weight-loss pill triggered legal threats from Novo Nordisk and a Department of Justice referral from the FDA, prompting Hims to stop offering the treatment. Community discussion is split between those who see this as a strategic removal of regulatory overhang ahead of its Super Bowl ad and those who criticize management's judgment, fearing long-term financial and reputational impact.

GhostwareOS (GHOST) is the Full-Stack Privacy Layer of Solana — a next-generation AI-driven infrastructure for encrypted communication, anonymous identity management, and untraceable transactions. By combining advanced zero-knowledge protocols with autonomous AI routing, GhostwareOS allows users and developers to operate invisibly across Web3. It powers decentralized apps that demand true digital anonymity, scalable privacy, and zero metadata leakage — restoring control to users in an overexposed internet age.

Ghost

GHOST is capturing attention as the "privacy layer of Solana," bolstered by integrations with Solflare and partnerships like Zebec, with its low market cap sparking community excitement for substantial growth and utility in the current market.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Preliminary Q4 and full-year 2025 revenue results for Briumvi exceeded expectations, with bullish 2026 guidance suggesting blockbuster status is on the horizon for the "best in class" MS drug. The community is actively discussing whether this strong growth will finally trigger a significant breakout or a much-anticipated buyout, despite persistent short interest and frustration over past stock performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Graphex Group Ltd. engages in the provision of landscape architectural services. It operates through the following segments: Graphene, Landscape Architecture, and Catering. The Graphene segment processes and sells graphite and graphene related products. The Landscaping Architecture segment offers its services to governments, private property developers, state-owned property developers, design services companies and engineering companies in the People's Republic of China (PRC) and Hong Kong. The Catering segment focuses on the operation of restaurants. The company was founded on November 25, 2013 and is headquartered in Hong Kong.

Graphex Group Limited - ADR

Up 5%

Down 5%

Markets are hovering near key levels, making the next 5% move especially important for sentiment. A breakout higher could reinforce the bull case, while a 5% drop may signal rising risk and tighter conditions. Which comes first?

Current Price	$0.226
Prev Close	$0.30
Open	$0.41
Dividend Yield	0.00%
50-Day Moving Average	$0.4682
Beta	-0.70
Avg. Volume	1,388.75
PE Ratio	-0.41

52-Week High	$1.73
52-Week Low	$0.0101
Market Capitalization	$10.64M
EPS (Annual)	-$0.8253
Price to Book	0.22
Revenue Per Employee	$103,767.88
Enterprise Value/EBITDA	N/A

GRFX
Graphex Group ADR

Feed

News

Sentiment

Fundamentals

Info

Latest GRFX News

GRFXGraphex Group ADR